Table 3.
Crude rates of cervical dysplasia incidence and progression by baseline CD4 count among 601 HIV-positive women in Johannesburg, South Africa
CD4 counta | Incidence or progression | Incidence only | Progression only | |||
---|---|---|---|---|---|---|
Rateb | 95% CL | Rateb | 95% CL | Rateb | 95% CL | |
<50 | 18.0 | 10.0, 32.6 | 25.8 | 12.9, 51.5 | 10.0 | 3.2, 31.0 |
50–199 | 15.4 | 11.4, 20.8 | 18.8 | 12.0, 29.5 | 13.4 | 8.9, 20.2 |
200–349 | 13.5 | 9.7, 18.7 | 18.1 | 12.2, 26.7 | 8.6 | 4.7, 15.5 |
≥350 + | 10.8 | 7.7, 15.2 | 11.6 | 7.8, 17.3 | 9.3 | 4.8, 17.8 |
CL, confidence limit.
Unit: cells/mm3
rates per 100 person-years.